Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Ethics Forum: Medical Ethical Considerations for COVID-19

David Y. Chen, MD, PhD, & Eric J. Gapud, MD, PhD, on behalf of the ACR Committee for Ethics & Conflicts of Interest  |  Issue: July 2020  |  June 8, 2020

The opinion also states, however, that this obligation is counterbalanced by the understanding that the physician workforce is a resource and not unlimited.

Institutions, therefore, must continually re-evaluate and balance the risks to providers against the need to be available to provide services in the future. Implicit is an obligation for healthcare systems to protect and support treating providers and to operate with a policy of communicating in a clear and transparent manner about these efforts in real time.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Protective Measures

The specific types and extent of measures taken to protect physicians are often determined by individual institutions. We believe such measures should carefully account for the following considerations to preserve the safety, and enhance the effectiveness, of our workforce:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The personal and family health status of deployed physicians, particularly those who have conditions that increase their own risk for adverse outcomes due to SARS-CoV-2 infection, should be given fair consideration. Specific examples associated with such increased risk include pregnancy, advanced age, cardiovascular or metabolic conditions, and the use of immunosuppressive drugs for existing comorbidities. A significant number of healthcare personnel with confirmed COVID-19 reported at least one underlying medical condition.6 Personal risk aside, many physicians also worry about transmitting infection to vulnerable family members.

Despite the demographically defined lower-risk category that trainees usually occupy, consideration should also be given to health status of trainees and their home contacts.

Structural features in redeployment schemes can incorporate safeguards to protect vulnerable physicians and those for whom risk is not well-defined. Some healthcare systems have tiered their redeployment plans based on such factors as age, comorbidities and proximity to internal medicine training. Deployments in these schemes are based on workforce needs, reserving frontline deployment of higher risk physicians only when absolutely necessary. High-risk providers are instead having their efforts directed to low-exposure support roles, including logistics, occupational health physician oversight and telemedicine to balance redeployment with preventing excess morbidity and mortality due to limited outpatient clinical operations within our own specialty.7

Refresher courses for general in-patient medical practice may be built into redeployment schemes in the form of online didactics or case-based materials. Redeployments often require providers to apply skills or knowledge that some may not have used for several years or that have not yet been tested or consolidated by experience. Sometimes, these assignments are offered as voluntary opportunities. In other cases, redeployment of trainees, including early graduation from medical school, leaves limited choices for these groups. Many retired physicians and healthcare workers also have offered to re-enter the workforce to address the increased demands during the pandemic.8

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Ethics Tagged with:COVID-19Ethics Forum

Related Articles
    nukeaf / shutterstock.com

    The History of Treating Lupus with Hydroxychloroquine

    June 15, 2020

    Given how unexpectedly front and center hydroxychloroquine has been in discussions about the treatment of COVID-19 this year, it makes sense to look at how it became so central to the treatment of a rheumatologic condition. In 1991, an article appeared in The New England Journal of Medicine that would alter the way rheumatologists approached…

    Updated ACP Ethics Manual Provides 6-Step Approach to Dilemmas

    January 15, 2019

    NEW YORK (Reuters Health)—The 2019 edition of the American College of Physicians (ACP) ethics manual provides a six-step approach to resolving ethical dilemmas and adds or expands sections that address emerging issues in 21st century medicine.1 “The Manual provides succinct guidance on issues that affect the patient-physician relationship, and also issues that have to do…

    AMA Updates Code of Medical Ethics

    January 17, 2017

    Eight years ago, the American Medical Association’s (AMA) Council on Ethical and Judicial Affairs embarked on a comprehensive review of the AMA Code of Medical Ethics. What emerged after years of hard effort, intensive feedback and thoughtful revisions was a modernized version of the guide, which the AMA House of Delegates voted to adopt in…

    The Many Facets of COVID-19: Experts Address Basic & Clinical Research Concepts in the COVID-19 Era

    November 23, 2021

    New concepts in autoimmunity & immunology are being discovered daily in research being conducted to understand the SARS-CoV-2 virus and its implications for rheumatology & all fields of medicine. Here are some insights shared by experts during day 1 of the Basic and Clinical Research Conference.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences